Search Results - "Janitzek, Christoph"
-
1
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
Published in PloS one (23-11-2015)“…Placental malaria caused by Plasmodium falciparum is a major cause of mortality and severe morbidity. Clinical testing of a soluble protein-based vaccine…”
Get full text
Journal Article -
2
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display
Published in Vaccine (27-06-2017)“…Graphical abstract…”
Get full text
Journal Article -
3
Virus‐like particles displaying major house dust mite allergen Der p 2 for prophylactic allergen immunotherapy
Published in Allergy (Copenhagen) (01-05-2020)Get full text
Journal Article -
4
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
Published in PloS one (30-07-2021)“…Yearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die…”
Get full text
Journal Article -
5
Virus-like particle display of HER2 induces potent anti-cancer responses
Published in Oncoimmunology (04-03-2018)“…Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20-30% of invasive breast cancers. Monoclonal antibody therapy is effective in…”
Get full text
Journal Article -
6
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Published in Journal of nanobiotechnology (27-04-2016)“…Virus-like particles (VLPs) represent a significant advance in the development of subunit vaccines, combining high safety and efficacy. Their particulate…”
Get full text
Journal Article -
7
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
Published in Scientific reports (27-03-2019)“…In Africa, cervical cancer and placental malaria (PM) are a major public health concern. There is currently no available PM vaccine and the marketed Human…”
Get full text
Journal Article -
8
Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses
Published in Malaria journal (08-11-2016)“…Malaria, caused by Plasmodium falciparum, continues to have a devastating impact on global health, emphasizing the great need for a malaria vaccine. The…”
Get full text
Journal Article -
9
Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
Published in Pharmaceutics (18-06-2022)“…The requirement of an undisrupted cold chain during vaccine distribution is a major economic and logistical challenge limiting global vaccine access. Modular,…”
Get full text
Journal Article -
10
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Published in Nature communications (12-01-2021)“…The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two capsid-like particle (CLP)-based vaccines displaying the…”
Get full text
Journal Article -
11
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Published in npj vaccines (15-11-2022)“…Development of B-cell-based hepatitis C virus (HCV) vaccines that induce broadly neutralizing antibodies (bNAbs) is hindered by extensive sequence diversity…”
Get full text
Journal Article -
12
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
Published in Vaccines (Basel) (15-07-2020)“…Due to constant antigenic drift and shift, current influenza-A vaccines need to be redesigned and administered annually. A universal flu vaccine (UFV) that…”
Get full text
Journal Article -
13
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration
Published in Vaccines (Basel) (06-02-2021)“…Capsid-like particle (CLP) displays can be used to enhance the immunogenicity of vaccine antigens, but a better understanding of how CLP vaccines are best…”
Get full text
Journal Article -
14
A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses
Published in African health sciences (01-01-2017)“…Background: Vaccine antigens targeting specific P. falciparum parasite stages are under pre-clinical and clinical development. It seems plausible that vaccine…”
Get full text
Journal Article -
15
Assessment of HIV-1 Patient Recruitability in the Republic of Guinea-Bissau Using African versus North American Hematology and Biochemistry Reference Intervals
Published in Clinical and Vaccine Immunology (01-08-2012)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
16
Abstract 716: A novel virus-like particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Overexpression of human epidermal growth factor receptor-2 (HER-2) occurs in about 20% of invasive breast cancers. Anti-HER-2 monoclonal antibody therapy is…”
Get full text
Journal Article -
17
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau
Published in AIDS research and human retroviruses (01-11-2013)“…We have designed a therapeutic HIV-1 vaccine concept based on peptides together with the adjuvant CAF01. Peptides represented 15 HLA-supertype-restricted…”
Get more information
Journal Article -
18
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
Published in Lab animal (01-12-2023)“…Placental malaria vaccines (PMVs) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading…”
Get full text
Journal Article -
19
-
20
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA: e0143071
Published in PloS one (01-11-2015)“…Placental malaria caused by Plasmodium falciparum is a major cause of mortality and severe morbidity. Clinical testing of a soluble protein-based vaccine…”
Get full text
Journal Article